PPT-Systemic Therapy for Breast Cancer

Adjuvant or Neoadjuvant Agustin A Garcia MD MMM Professor of Medicine and Section Chief Hematology Oncology Charles W McMullin III and Richard Paul Grace Chair in Cancer Research Louisiana State University. DR. A. AKHATOR FWACS, FICS. SENIOR LECTURER DELSU . CONSULTANT SURGEON DELSUTH. PRE-TEST. Breast cancer is the most common cancer in women in Nigeria . Breast cancer is the most common cause of cancer related deaths. Joyce O'Shaughnessy, MD. Kimberly Blackwell, MD. Hope . Rugo. , MD. Reminder: feedback is appreciated. You will be prompted at the end for your feedback.. Updates on Chemotherapy and Other Novel Agents. Breast Cancer Overview. The . most common breast cancer starts in cells of the . ducts.. Breast . cancer is the second most common cancer for women in the U.S. . Reference . 2. Breast Cancer Statistics. Rachna Raman MD MS. Hematology and Medical Oncology. Bon Secours Cancer Institute at St. Mary’s Hospital. Objectives. Risk factors . Screening guidelines and controversies. Screening and management of patients at high risk for breast cancer. Cancer-Treatment-Induced Bone Loss (CTIBL). Clodronate and Bone Mineral Density (. Hip. ). Bone Mineral Density Substudy --ABCSG-12: Effect of Zoledronic Acid. Percent Change, Lumbar Spine. Denosumab for CTIBL (. Trial Portfolio. Any Receptor Status. Triple Negative. Clinical Trial Contacts. A content placeholder. Use for text, graphics, tables and graphs. You can change this text or delete it.. Here is a placeholder for more text. You may delete this text. Targeting endocrine-resistance pathways in breast cancer Clara Natoli, Chieti Endocrine responsive breast cancer Luminal A High expression of ER & ER-related genes Lower Julie R. Gralow, M.D.. Director, Breast Medical Oncology. Jill Bennett Endowed Professor of Breast Cancer. Professor, Global Health. University of Washington School of Medicine. Fred Hutchinson Cancer Research Center. Cleveland Clinic Florida. Breast Surgeon . September 25, 2018. Breast Cancer . Highly prevalent disease . Limited to female sex in all but < 1% of cases in USA. SEER . Cancer. . Stat Facts: Female Breast Cancer. Rajiv Doddamani. . PGY – 3, Internal Medicine . . St. Joseph Mercy Ann Arbor . Learning objectives . Explain the principles of breast cancer screenings . group. of diseases. . All forms of cancer cause cells in the body to change and grow out of control. . Most types of cancer cells form a lump or mass called a . tumor. . . The tumor can invade and destroy healthy tissue. Cells from the tumor can break away and travel to other parts of the body. There they can continue to grow. . Most of these lesions are benign. Breast cancer is 2. nd. most common cause of cancer deaths in women, following. carcinoma of the lung. . The clinical significance of the . benign. conditions:. 1- possible clinical confusion with malignancy. Breast Cancer in the US . Breast Cancer is estimated to affect . over 230,000 . women . annually in the US. Based on SEER Database rates from 2009-2011, the . cumulative lifetime risk. of an average woman in the general US population is 12.3%. Jo Anne Zujewski, M.D.. June 2019. Thimphu. , Bhutan. Define the breast cancer. Is the cancer operable?. Stage 1: systemic therapy after surgery (and radiation if breast conservation). Stage 2: systemic therapy before or after therapy.